Matches in Nanopublications for { ?s ?p "[SLC22A18 downregulation via promoter methylation is associated with the development and progression of glioma, suggesting that SLC22A18 is an important tumor suppressor in glioma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- assertion description "[SLC22A18 downregulation via promoter methylation is associated with the development and progression of glioma, suggesting that SLC22A18 is an important tumor suppressor in glioma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP931744.RAHwb_msGCLeNeqeHT8gH164Qb2x6wm28onA5inagOv9o130_assertion description "[SLC22A18 downregulation via promoter methylation is associated with the development and progression of glioma, suggesting that SLC22A18 is an important tumor suppressor in glioma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP931744.RAHwb_msGCLeNeqeHT8gH164Qb2x6wm28onA5inagOv9o130_provenance.
- NP925405.RAzCXtQAKk98rIfNK99flwNGObkZZERdQzaUVYI0sSOFg130_assertion description "[SLC22A18 downregulation via promoter methylation is associated with the development and progression of glioma, suggesting that SLC22A18 is an important tumor suppressor in glioma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP925405.RAzCXtQAKk98rIfNK99flwNGObkZZERdQzaUVYI0sSOFg130_provenance.